Selected Releases
05 01 09
> Nidus Center Announces Move to BRDG
Park at the Danforth Plant Science Center
Bio-Research and Development Growth (BRDG) Park at the Danforth Plant Science Center announced that the Nidus Center for Scientific Enterprise has signed a lease for 15,000 sq. ft. in Building I, an 110,000 sq. ft., four-story facility scheduled to open in June 2009.
02 17 09
> Divergence Raises $11.8 Million in
Series C Financing
Divergence, a world leader in developing products for the control of parasites in agriculture and medicine, today announced that it has raised $11.8 million in a Series C financing round that will further its efforts to create solutions for one of the major causes of crop yield loss for farmers.
04 17 08
> Akermin Co-Founder
Is 2008 Recipient of
American Chemical Society Award
Dr. Shelley Minteer, professor of chemistry at Saint Louis University
and co-founder of Akermin, is the 2008 recipient of the American
Chemical Society St. Louis Award, recognizing her leading research
in biofuel cells and enzyme immobilization and stabilization.
04 04 08
> Victoria Gonzalez Named
President and
CEO of Nidus Center
Nidus Center for Scientific Enterprise today named Victoria Gonzalez
as president and chief executive officer, effective April 15.
She succeeds Robert Calcaterra whose retirement was previously
announced.
03 27 08
> Apath Signs
Exclusive Agreement with
Celsis IVT
Celsis International plc, the life sciences products and laboratory
services company, today announces that its Celsis In Vitro Technologies
(Celsis IVT) division has signed an exclusive global market development
agreement with Apath LLC to assist customers in the evaluation
of drug candidates for their cytotoxicity and efficacy against
the Hepatitis C virus.
03 06 08
> Monsanto
and Divergence Sequence
Soybean Cyst Nematode Genome
Monsanto Company and Divergence announced today they have completed
the most comprehensive sequence of the soybean cyst nematode (SCN)
genome to date, making it the first available draft of this organism’s
genome. Today’s announcement by the companies represents
a major advancement in the available research data on this crop
pest.
11 02 07
> Akermin Raises
$5 Million in Just
Completed Financing Round
Akermin’s technology will allow stabilized enzymes to replace
many precious metals now used as catalysts in fuel cells, and improve
the performance of enzymes in food processing and fine chemical
production.
|
Selected Articles
06 18 08 St.
Louis Post-Dispatch Akermin
> Akermin Wins Army Contract to Develop
Fuel Cell Technology
Akermin Inc. has signed a one-year, $1 million contract with the Army to develop prototype fuel cells that will power ground sensors that transmit data to military bases from war zones, borders, and other top-secret locales.
06 03 08 St.
Louis Post-Dispatch Akermin
> Akermin Biofuel Cell Keeps Going,
and Going ...
With apologies to Energizer's drum-pounding pink bunny, a new symbol of long-lasting energy is being deployed by another St. Louis-area company. The company Akermin Inc. developed a lab-scale biofuel cell that has generated power continuously for 3½ years. And it's still going.
02 15 08 St.
Louis Post-Dispatch Nidus
> President
Bob Calcaterra Is Leaving
Biotech Incubator
Bob Calcaterra proudly presided over the Tuesday night graduation
of three companies from the Nidus Center for Scientific Enterprise,
a biotech business incubator he has run since its inception. It
wasn't the first such ceremony in the Creve Coeur center's eight
years. But it was Calcaterra's last as president.
02 08 08 St.
Louis Post-Dispatch Metabolix
> Missouri
Hopes to Cash in on Plastic
Making Oilseed
Imagine an oilseed, not part of the food chain, that can produce
biodegradable plastic and improve the economics of making biodiesel.
That is the vision of scientists at Cambridge, Massachusetts-based
Metabolix Inc. and their research partners at the Donald Danforth
Plant Science Center in Creve Coeur.
01 02 08 St.
Louis Post-Dispatch Cervimark
> Startup
Targets Pre-Term Births
Obstetrician Jodie Rai is tired of seeing the number of babies born too soon
increase year after year in this country, with little that she and her colleagues
can do about it. So she has partnered with researcher Robert Kokenyesi to form
a local company and develop a test that might be able to predict, for the first
time, which women are likely to deliver at less than 37 weeks of pregnancy, the
definition of a pre-term birth. |
